Antimüllerian Hormone to Determine Polycystic Ovarian Morphology: The APHRODITE Study

    September 2021 in “ Fertility and Sterility ”
    Alexandra Dietz de Loos, Martin Hund, Katharina Buck … Joop S.E. Laven
    Studysummary This study found that the Elecsys AMH Plus immunoassay with a cutoff of 3.2 ng/mL is effective for diagnosing polycystic ovarian morphology, showing high sensitivity and specificity across different PCOS phenotypes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on fertstert.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Accuracy of Anti-Müllerian Hormone and Total Follicle Count to Diagnose Polycystic Ovary Syndrome in Reproductive Women Taiwanese Journal of Obstetrics & Gynecology · 2018
    2. The Prevalence and Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Human Reproduction · 2016
    3. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004